Market Overview

Afternoon Market Losers

Related INSM
H.C. Wainwright: Time To Buy Insmed
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now
Related IDCC
InterDigital Expands Convida Wireless Research Scope With Sony and Enters Into Patent License Agreement
Benzinga's Top Initiations

Insmed Incorp. (NASDAQ: INSM) plunged 14.63% to $10.21 amid a Phase 3 trial of Arikace which met a primary endpoint, but a company slideshow which revealed competitor Novartis's (NYSE: NVS) Tobi drug showed more favorable results.

InterDigital (NASDAQ: IDCC) dropped 12.83% to $38.92 after the company lost 1st round of case against ZTE, Huawei, and Nokia.

TherapeuticsMD (NYSE: TXMD) tumbled 12.54% to $2.65 after the company announced that the company had been added to the 2013 Russell 3000® Index.

News Corp. (NASDAQ: FOXA) dropped 9.88% to $29.37 after the company split its business into two companies.

NTS (NYSE: NTS) dipped 10.78% to $1.40.

Fleetmatics Group PLC (NYSE: FLTX) traded down 3.40% to $32.10 after the company filed to sell 7 million ordinary shares for holders.

Document Security Systems (NYSE: DSS) dropped 13.91% to $1.98 after the company completed its merger with Lexington Technology Group.

Posted-In: News Economics Markets Movers


Related Articles (DSS + FLTX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters